Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-19
DOI: 10.2147/dddt.s607142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Zhongfu Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Lupus Nephritis, Triterpenes, Saponins, Ferroptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, People's Republic of China.
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, People's Republic of China.
ORCID-Profile: Lili Cheng, Ming Li
Zitieren
APA
Tang, Z., Cheng, L., Li, M., & Huang, C. (2026). Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s607142
Vancouver
Tang Z, Cheng L, Li M, Huang C. Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s607142
BibTeX
@article{Tang2026,
author = {Tang, Zhongfu and Cheng, Lili and Li, Ming and Huang, Chuanbing},
title = {Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--19},
doi = {10.2147/dddt.s607142}
}
EUVIMED